RESI San Francisco 2020 – Agenda Announced

21 Nov

By Lucy Parkinson, VP of Investor Research, LSN

On January 14th, RESI will be back in San Francisco, and LSN would like to present the panel and workshop agenda.  In addition to the all-new RESI Featured Company Pitch Sessions, RESI SF will feature three tracks of panel and workshop content, and RESI’s industry-leading Partnering from 8am-5pm.

RESI panels feature a moderator and 4 panelists who are experienced investors and industry experts who can guide entrepreneurs on what they need to do to raise capital.  RESI will feature panels focused on specific verticals, such as Early Stage Therapeutics, AI in Healthcare, Oncology Innovation, and an all-new panel on Investing In Life Science Tools.  Other panels focus on key investor groups such as Big Pharma, Corporate Venture Capital, Impact Investors, and Family Offices & Angels.  Additionally, RESI will include a half-day Asia Investors Track from 1.00-5.00pm, in which investors based in the Asia-Pacific region share their strategies on investing in global technology.

RESI’s workshops will include expert presentations on key issues for early stage entrepreneurs, including Company Valuation for Fundraising from Venture Valuation, and Negotiating Term Sheets from McDermott, Will & Emery, and an advice session from experts from the National Institutes of Health.

We hope you can join us during the San Francisco healthcare conference week to take part in this jam-packed agenda.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: